Minimal late radiation toxicity and transient early toxicity following postoperative definitive intent conformal radiation therapy (20 × 2.5 Gy) for canine apocrine gland anal sac adenocarcinoma.
dogs
perianal
radiotherapy
tolerability
Journal
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
ISSN: 1740-8261
Titre abrégé: Vet Radiol Ultrasound
Pays: England
ID NLM: 9209635
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
21
08
2021
received:
04
05
2021
accepted:
10
09
2021
pubmed:
15
12
2021
medline:
1
4
2022
entrez:
14
12
2021
Statut:
ppublish
Résumé
Postoperative radiation therapy (RT) may be beneficial for dogs with anal sac apocrine gland adenocarcinoma (ASAC). Clinically significant late toxicities have been reported in up to 65% of dogs with perianal tumors following non-conformal definitive RT, particularly when fractions of 3 Gy or higher are prescribed. The primary objective of this prospective, descriptive study was to evaluate tolerability of a novel 3D conformal RT (3DCRT) protocol in a group of dogs. Dogs with ASAC were prospectively enrolled if clients elected RT following surgery. The planning target volume was prescribed 50 Gy in 2.5 Gy fractions using 6 MV photons and administered over 26 days. Early and late radiation toxicities were graded according to standardized criteria. Thirteen dogs were initially enrolled but 1 was excluded due to a high risk of anesthesia-related mortality. Seven dogs presented with early stage disease. Median follow up time was 771 days (91-2223). Transient grade 3 dermatitis and anusitis developed in all dogs, with resolution within 4 weeks. Two dogs developed transient grade 2 late colitis. Locoregional failure in the irradiated field was documented in one dog at 738 days. All-cause median survival time was 771 days (95% confidence interval: 510 → 2223 days). Findings indicated that this fractionation may be safely administered to the canine anus and pelvic canal using 3DCRT, although acute toxicity should be anticipated. Further prospective studies are needed in order to confirm long-term tolerability and efficacy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
224-233Informations de copyright
© 2021 American College of Veterinary Radiology.
Références
Polton GA, Brearley MJ. Clinical stage, therapy, and prognosis in canine anal sac gland carcinoma. J Vet Intern Med. 2007; 21:274-280.
Ross JT, Scavelli TD, Matthiesen DT, et al. Adenocarcinoma of the apocrine glands of the anal sac in dogs: a review of 32 cases. J Am Anim Hosp Assoc. 1991;27:349-355.
Potanas CP, Padgett S, Gamblin RM. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005-2011). J Am Vet Med Assoc 2015;246:877-884.
Wouda RM, Borrego J, Keuler NS, et al. Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs. Vet Comp Oncol. 2016;14:67-80.
McQuown B, Keyerleber MA, Rosen K, et al. Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999-2013). Vet Comp Oncol. 2017;15:840-851.
Meier V, Polton G, Cancedda S, et al. Outcome in dogs with advanced (stage 3b) anal sac gland carcinoma treated with surgery or hypofractionated radiation therapy. Vet Comp Oncol. 2017;15:1073-1086.
Turek MM, Forrest LJ, Adams WM, et al. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991-2001). Vet Comp Oncol. 2003;1:94-104.
Anderson CR, McNiel EA, Gillette EL, et al. Late complications of pelvic irradiation in 16 dogs. Vet Radiol Ultrasound. 2002;43:187-192.
Arthur JJ, Kleiter MM, Thrall DE, et al. Characterization of normal tissue complications in 51 dogs undergoing definitive pelvic region irradiation. Vet Radiol Ultrasound. 2008;49:85-89.
Emms SG. Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy. Aust Vet J. 2005;83:340-343.
Bowlt KL, Friend EJ, Delisser P, Murphy S, Polton G Temporally separated bilateral anal sac gland carcinomas in four dogs. J Small Anim Pract 2013;54(8):432-612.
Fowler JF. 21 years of biologically effective dose. Br J Radiol. 2010; 83:554-568.
Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys. 1994;21(4):581-618.
Ladue T, Klein MK. Veterinary radiation therapy oncology G. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound. 2001;42:475-476.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31:1341-1346.
LeBlanc AK, Atherton M, Bentley RT, et al. Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Vet Comp Oncol. 2021;19:311-352. 2021.
Serra Varela JC, Pecceu E, Handel I, et al. Tolerability of a rapid-escalation vinblastine-prednisolone protocol in dogs with mast cell tumours. Vet Med Sci. 2016;2:266-280.
Microsoft Corporation. Microsoft Excel. 2018. Available from: https://office.microsoft.com/excel
R core Team. R: A language and environment for statistical computing. 3.2.3. ed. R Foundation for Statistical Computing, 2020;
Therneau T, A package for survival analysis in R. 2020;
Alboukadel K, Marcin K, Przemyslaw B, et al. survminer: drawing Survival Curves using ‘ggplot2.’ 2020;
Skorupski KA, Alarcon CN, de Lorimier LP, et al. Outcome and clinical, pathological, and immunohistochemical factors associated with prognosis for dogs with early-stage anal sac adenocarcinoma treated with surgery alone: 34 cases (2002-2013). J Am Vet Med Assoc. 2018;253:84-91.
Keyerleber MA, Gieger TL, Erb HN, et al. Three-dimensional conformal versus non-graphic radiation treatment planning for apocrine gland adenocarcinoma of the anal sac in 18 dogs (2002-2007. Vet Comp Oncol. 2012;10:237-245.
Meier V, Besserer J, Roos M, et al. A complication probability study for a definitive-intent, moderately hypofractionated image-guided intensity-modulated radiotherapy protocol for anal sac adenocarcinoma in dogs. Vet Comp Oncol. 2019;17:21-31.
Keyerleber MA, Ferrer L. Effect of prophylactic cefalexin treatment on the development of bacterial infection in acute radiation-induced dermatitis in dogs: a blinded randomized controlled prospective clinical trial. Vet Dermatol. 2018;29(1):37-e18.